Pharmacovigilance Reporting Goes Digital in Kenya
Wednesday, May 8, 2013
Monitoring and reporting of adverse drug reactions (ADRs) and poor-quality human medicines has gone digital in Kenya.
Medical experts and patients can now detect, assess, and report unpleasant reactions to pharmaceutical products in real time to the Pharmacy and Poisons Board’s (PPB) National Pharmacovigilance Centre. The goal is to ensure and enhance patient safety.
PPB began establishing a process of monitoring and reporting ADRs in 2004, and the National Pharmacovigilance System was officially launched on June 9, 2009.
Source: Management Sciences for Health (link opens in a new window)
- Categories
- Health Care, Impact Assessment
